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Abstract
Background: Transfection of cells with gene-specific, single-stranded oligonucleotides can induce
the targeted exchange of one or two nucleotides in the targeted gene. To characterize the features
of the DNA-repair mechanisms involved, we examined the maximal distance for the simultaneous
exchange of two nucleotides by a single-stranded oligonucleotide. The chosen experimental system
was the correction of a hprt-point mutation in a hamster cell line, the generation of an additional
nucleotide exchange at a variable distance from the first exchange position and the investigation of
the rate of simultaneous nucleotide exchanges.
Results:  The smaller the distance between the two exchange positions, the higher was the
probability of a simultaneous exchange. The detected simultaneous nucleotide exchanges were
found to cluster in a region of about fourteen nucleotides upstream and downstream from the first
exchange position.
Conclusion: We suggest that the mechanism involved in the repair of the targeted DNA strand
utilizes only a short sequence of the single-stranded oligonucleotide, which may be physically
incorporated into the DNA or be used as a matrix for a repair process.
Background
Transfection of cells with single-stranded oligonucle-
otides showing a mismatch to a target gene sequence can
result in an exchange of the single nucleotide in the
genomic DNA [1-8]. The repair mechanisms involved in
this targeted gene alteration (TGA) are still under discus-
sion [9-12]. Previous findings indicate that in an initial
step single-stranded oligonucleotides anneal to the tar-
geted strand of the gene and that RAD51, RAD54  and
XRCC2 are involved in this process [13-15]. In a second
step the repair of the targeted strand takes place and the
oligonucleotide is either physically incorporated into the
target DNA [8,16-18] or serves as a matrix for specific
repair mechanisms. Proteins involved in mismatch repair
(MMR) seem to be crucial for this nucleotide exchange in
yeast but not in mammalian cells [19]. Another possible
repair mechanism involved in this step is nucleotide
exchange repair [20]. The participation of double-strand
break repair and homologous recombination has also
been suggested [8,21-26]. The alteration of the sequence
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of the target strand results in a new mismatch between the
two strands of DNA helix. In a third step the repair of
emerged mismatches between the corrected targeted
strand and its complementary strand via different repair
pathways takes place, thus generating an intact DNA helix
[4].
In the present study we sought to characterize one feature
of the mechanisms involved in the targeted gene altera-
tion, namely the extent of the sequence of the single-
stranded oligonucleotide which is used for the correction
of the targeted gene.
One method to examine this is the transfection of oligo-
nucleotides carrying at least two specific markers and the
detection of their simultaneous appearance in the target
DNA. In our study we used two mismatches of the oligo-
nucleotides to the target sequence as markers. The first
marker is a nucleotide which alters the premature stop
codon (TGA) in the hprt deficient V79-151 cells to a codon
for Arginine (hprt position 151, CGA) or for Cysteine (hprt
position 153, TGC) (Table 1). Both exchanges restore hprt
function and thereby allow the selection of cells by incu-
bation in HAT medium [2]. The second marker is a nucle-
otide the exchange of which leads to a silent mutation in
hprt (Table 1). The simultaneous exchange of two nucle-
otides in hprt by transfection with single-stranded oligo-
nucleotides carrying two mismatches has been
demonstrated by us before [27] and in an episomal yeast
target gene by Agarwal et al. [28]. Agarwal et al. carried out
in vitro experiments with oligonucleotides carrying two
mismatches to an episomal target plasmid. The first mis-
match directed the repair of a hygromycin point mutation
and the second generated a silent mutation which leads to
a new restriction enzyme cleavage site. A similar approach
was used to examine the physical incorporation of trans-
fected oligonucleotides into the DNA [18]. Here, the cor-
rection of a point mutation and the simultaneous
occurrence of a biotin labeled nucleotide were used as
markers. We suggest that if DNA sequence analysis of
transfected cells shows the exchange of both targeted
nucleotides, at least the region of the oligonucleotide sit-
uated between the two mismatches has been used for
TNE.
There are several preconditions to our approach. First, the
observed exchanges have to be located in cis on the same
allele of the gene. As hprt is an X-chromosomal gene and
the cell line we used derives from a male hamster (V79-
151), each cell carries only one hprt allele and therefore no
additional exchange position exists. A second prerequisite
is that the exchange of both nucleotides takes place simul-
taneously. In our cellular system, 104 cells were trans-
fected per well and the correction rate of about four clones
per 106 transfected cells is very low [2]. It is therefore quite
unlikely that two independently targeted nucleotide
exchanges occur in one well and, more importantly, in
one cell. The next prerequisite for our approach is the
intracellular uptake of oligonucleotides which was sur-
veyed through transfection with fluorescently labeled oli-
gonucleotides. Furthermore, it is possible that the
intracellular integrity of the oligonucleotides is affected by
the activity of exonucleases which accelerate the degrada-
tion of oligonucleotides [18]. This is important for our
experiments because it might influence the observed
nucleotide exchange rate. We therefore determined the
minimal distance between the second exchange nucle-
otide and the 3'-end of the oligonucleotide idem. Finally,
the distance between the two mismatched nucleotides
should not affect the affinity of the oligonucleotides to the
target sequence. This can be monitored through differ-
ences in correction rates of the selectable hprt mutation.
Also, the specific sequence environment of the first
exchange nucleotide may influence this kind of experi-
ment. This can be tested by comparing experiments using
oligonucleotides correcting the hprt mutation at different
positions.
Our investigations showed that the smaller the distance
between the two mismatches, the higher the probability
of a simultaneous exchange became. The simultaneous
exchanges were found to be clustered in a region of about
fourteen nucleotides upstream and downstream of the
first exchange position.
Results
Investigation of the minimal distance of the second 
mismatch nucleotide from the 3'-end of the 
oligonucleotides
The oligonucleotides used were delivered into the cell by
magnet-assisted transfection. The cellular uptake was
tested by transfection with 3'-end FITC labeled 5'-TA-
clamp oligonucleotides. After incubation for one hour,
fluorescence microscopy revealed an uptake of the labeled
oligonucleotides into the nucleus in 80 per cent of V79-
151 cells. Recently, we observed a rapid degradation of
these oligonucleotides in isolated cytoplasm and nucleo-
plasm by exonuclease and endonuclease activities
(unpublished data, M Wuepping). As a result of intracel-
lular degradation through exonucleases the second
marker nucleotide lying closer to the 3'- or 5'-end of the
oligonucleotide could be removed faster than the first
nucleotide positioned in the middle of the sequence and
therefore not be exchanged. Thus the rate of simultaneous
nucleotide exchange might be influenced by the distance
of the second mismatch from the 3'- or 5'-end of the oli-
gonucleotide. To test this hypothesis, cells were trans-
fected with 5'-TA clamp modified oligonucleotides
showing the first mismatch at position 153 at a distance
of twenty nucleotides to the TA-clamp (Fig. 1A). UsingBMC Molecular Biology 2008, 9:14 http://www.biomedcentral.com/1471-2199/9/14
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these oligonucleotides the stop codon (TGA) of the V79-
151 cells is replaced by a codon for cysteine (TGC, posi-
tion 153). The second mismatch resulting in a silent
mutation is located at position 147 at a distance of six,
twelve, eighteen, twenty-four and thirty nucleotides from
the unmodified 3'-end (Fig. 2B, Table 2). The reduction of
the exchange rate of the second mismatch nucleotide
should indicate the interfering effect of 3'-exonucleases.
After about two weeks HAT resistant clones could be
found in all experiments (Additional file 1) and DNA
sequencing showed the correction at hprt position 153 in
all sequenced clones. In several clones an additional
exchange at position 147 was detected (Fig. 2A). The rela-
tive nucleotide exchange rate at position 147 and the
number of clones varied depending on the distance of the
second mismatch nucleotide from the unmodified 3'-end
(Table 3). The total number of clones per 106 transfected
cells increased with decreasing distance of the second mis-
match from the 3'-end. However, we found a reduction in
the exchange rate of the second nucleotide using oligonu-
cleotides with their second mismatch at a distance of six
nucleotides from the 3'-end. Therefore, the 5'-TA-clamp
oligonucleotides used in the following experiments car-
Table 1: Hprt sequences
Sequences of coding strand of hprt intron 2 and exon 3 in V79 wildtype and V79-151 cells.
V79 wildtype position 151
DNA sequence 5'-ttgtag G ACT GAA AGA CTT GCC CGA GAT GTC ATG AAA GAG ATG GGA-3
amino acids Thr Glu Arg Leu Ala Arg Asp Val Met Lys Glu Met Gly
V79-151 position 151
DNA sequence 5'-ttgtag G ACT GAA AGA CTT GCC TGA GAT GTC ATG AAA GAG ATG GGA-3
amino acids Thr Glu Arg Leu Ala Stop Asp Val Met Lys Glu Met Gly
Positions of the intended first nucleotide exchanges for correcting the hprt mutation.
Exchange of nucleotide on position 151
DNA sequence 5'-ttgtag G ACT GAA AGC CTT GCC CGA GAT GTT ATG AAA GAG ATG GGA-3'
amino acids Thr Glu Arg Leu Ala Arg Asp Val Met Lys Glu Met Gly
Exchange of nucleotide on position 153
DNA sequence 5'-ttgtag G ACT GAA AGC CTT GCC TGC GAT GTT ATG AAA GAG ATG GGA-3'
amino acids Thr Glu Arg Leu Ala Cys Asp Val Met Lys Glu Met Gly
Positions of the intended second nucleotide exchange generating a silent mutation
Position Base exchange Sequence of coding strand of hprt intron 2 in V79-151 cells.
141 A to G 5'-ttgtag G ACT GAG AGA CTT GCC TGA GAT GTC ATG AAA GAG ATG GGA-3
144 A to G 5'-ttgtag G ACT GAA AGG CTT GCC TGA GAT GTC ATG AAA GAG ATG GGA-3
147 T to C 5'-ttgtag G ACT GAA AGA CTC GCC TGA GAT GTC ATG AAA GAG ATG GGA-3
150 C to T 5'-ttgtag G ACT GAA AGA CTT GCT TGA GAT GTC ATG AAA GAG ATG GGA-3
156 T to C 5'-ttgtag G ACT GAA AGA CTT GCC TGA GAC GTC ATG AAA GAG ATG GGA-3
159 C to T 5'-ttgtag G ACT GAA AGA CTT GCC TGA GAT GTT ATG AAA GAG ATG GGA-3
165 A to G 5'-ttgtag G ACT GAA AGA CTT GCC TGA GAT GTC ATG AAG GAG ATG GGA-3
168 G to A 5'-ttgtag G ACT GAA AGA CTT GCC TGA GAT GTC ATG AAA GAA ATG GGA-3
The table shows the sequence of coding strand of hprt intron 2 (lower case letters) and exon 3 (upper case letters) in V79 wildtype cells and V79-151 
cells, which carry a stop codon at position 151. Also shown is the sequence of coding strand of hprt after base exchange at position 151 or 153 and 
after base exchange at the second mismatch position, which generates a silent mutation. The exchanged bases are indicated in bold. The respective 
second base exchanges are generated through the following oligonucleotides: position 141: oligonucleotide H7-151-141; position 144: H5-151-144; 
position 147: H3-151-147, O45-151-147, C153-147; position 150: H2-151-150, O45-151-150, C153-150; position 156: H4-151-156, O42-151-156, 
C153-156; position 159: H6-151-159, O25-151-159, O30-151-159, O45-151-159, O48-151-159, C153-159; position 165: H8-151-165; position 168: 
H9-151-168.BMC Molecular Biology 2008, 9:14 http://www.biomedcentral.com/1471-2199/9/14
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ried their second mismatch nucleotide at a distance of
twelve nucleotides or more from the unmodified 3'-end.
Nucleotide exchange at hprt position 151 and 
simultaneous exchange of an additional nucleotide at 
various distances
Next, the simultaneous exchange of two nucleotides at
different positions was investigated. We transfected the
V79-151 cells with 5'-TA-clamp oligonucleotides showing
a first mismatch to the targeted mutated hprt sequence at
position 151 and a second at position 141/144/147/150/
156/159/165 or 168, respectively (Fig. 1A; Tables 1 and
2). After about two weeks one to seven HAT resistant
clones per 106 transfected cells could be found in each
transfection experiment (Additional file 1). After transfec-
tion with a control oligonucleotide carrying only one mis-
match to the target sequence we obtained on average 4.9
clones per 106 transfected cells. The insertion of an addi-
tional mismatch to the target sequence at a distance of one
to eight nucleotides from the first mismatch reduced the
number of clones by about fifty percent (Fig. 3). This
reduction might be due to a reduced affinity of the oligo-
nucleotides with two mismatches to the target sequence.
As the number of clones was almost the same among all
of these oligonucleotides we assume that they all exhibit
a comparable affinity to the target strand. Interestingly, in
experiments with oligonucleotides carrying the second
mismatch at a distance of ten to seventeen nucleotides
from the first mismatch the number of clones received
was comparable to experiments using the oligonucleotide
carrying only one mismatch.
DNA sequencing of each HAT resistant clone showed the
correction of the point mutation at hprt position 151. In
several clones the additional intended exchanges at posi-
tions 141 to 168 were found (Fig. 2B). The number of
clones showing both exchanges varied depending on the
distance of the second exchange position to the first
exchange at hprt position 151 (Table 3, Fig. 4). The smaller
the distance between the two exchange positions the
higher the rate of simultaneous exchanges was.
Simultaneous nucleotide exchange at hprt position 153 
and additional positions in various distances
The specific sequence environment of the first exchange
nucleotide may influence this kind of experiment. There-
fore we repeated these experiments using oligonucle-
otides correcting the hprt mutation at hprt position 153
(Fig. 1A, Table 2). The second nucleotide exchange gener-
ated by these oligonucleotides was intended at hprt posi-
tions 147, 150, 156 and 159. DNA sequencing showed an
Sequence analyses of hprt Figure 2
Sequence analyses of hprt. Sequence analysis of the hprt 
gene isolated from V79-151 cell clones after transfection 
with oligonucleotide C59-153-147 (A) and H3-151-147 (B). 
Arrows point to the position of the successfully exchanged 
nucleotides. The upper base code shows the sequence of the 
analyzed clones, the lower base code the original sequence of 
the transfected V79-151 cells.
Structure of the oligonucleotides and relative position of the  two mismatches Figure 1
Structure of the oligonucleotides and relative posi-
tion of the two mismatches. (A) Sequence and structure 
of the oligonucleotides modified with a TA-clamp generating 
a first nucleotide exchange at position 153 (light blue) ore 
151 (dark blue) respectively. The possible positions for the 
second (silent) exchange are given in red. (B) Structure of the 
oligonucleotides showing the first mismatch at position 153 
and the second mismatch at position 147 in various distance 
from the unmodified 3'-end. (C) Structure of the oligonucle-
otides with different length, modified with PTO and showing 
the first mismatch at position 151 and the second mismatch 
at position 159.BMC Molecular Biology 2008, 9:14 http://www.biomedcentral.com/1471-2199/9/14
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exchange of the first mismatch at position 153 in all of the
received clones. The number of clones after transfection
with the control oligonucleotide correcting only position
153 (H153-1T) was higher than using the control oligo-
nucleotide correcting only position 151 (H1-151) (18
clones/106 cells versus 4.9/106) (Additional file 1). The
differences between the two oligonucleotides may be
related to the specific sequence environment resulting in
different affinities to the target sequence. In the experi-
ments with oligonucleotides carrying two mismatches,
the average number of HAT resistant clones was about 3.5
clones per 106 transfected cells and therefore also higher
than in the corresponding experiments exchanging the
first nucleotide at position 151 (Additional file 1).
Again, we observed that the exchange rate of the second
nucleotide depends on its distance to the first exchange
position. We found that the longer the distance between
Table 2: Sequences of single-stranded oligonucleotides binding at the hprt coding strand
Oligonucleotide Sequence
Oligonucleotides with a first mismatch at position 153 and a second mismatch at position 147 in different distances to the 3'-end
C47-153-147 5'-TATATCCCCATATACCCATCTCTTTCATGACATCGCAGGCGAGTCTT-3'
C53-153-147 5'-TATATCCCCATATACCCATCTCTTTCATGACATCGCAGGCGAGTCTTTCAGTC-3'
C59-153-147 5'-TATATCCCCATATACCCATCTCTTTCATGACATCGCAGGCGAGTCTTTCAGTCCTACAA-3'
C65-153-147 5'-TATATCCCCATATACCCATCTCTTTCATGACATCGCAGGCGAGTCTTTCAGTCCTACAAAAATAG-3'
C71-153-147 5'-
TATATCCCCATATACCCATCTCTTTCATGACATCGCAGGCGAGTCTTTCAGTCCTACAAAAATAGAATCAC-
3'
Oligonucleotides with a first mismatch at position 151 and a second mismatch in various distance to the first
H1-151 5'-TATATCCCCATATACCCATCTCTTTCATGACATCTCGGGCAAGTCTTTCAGTCCTACAA-3'
H7-151-141 5'-TATATCCCCATATACCCATCTCTTTCATGACATCTCGGGCAAGTCTCTCAGTCCTACAA-3'
H5-151-144 5'-TATATCCCCATATACCCATCTCTTTCATGACATCTCGGGCAAGCCTTTCAGTCCTACAA-3'
H3-151-147 5'-TATATCCCCATATACCCATCTCTTTCATGACATCTCGGGCGAGTCTTTCAGTCCTACAA-3'
H2-151-150 5'-TATATCCCCATATACCCATCTCTTTCATGACATCTCGAGCAAGTCTTTCAGTCCTACAA-3'
H4-151-156 5'-TATATCCCCATATACCCATCTCTTTCATGACGTCTCGGGCAAGTCTTTCAGTCCTACAA-3'
H6-151-159 5'-TATATCCCCATATACCCATCTCTTTCATAACATCTCGGGCAAGTCTTTCAGTCCTACAA-3'
H8-151-165 5'-TATATCCCCATATACCCATCTCCTTCATGACATCTCGGGCAAGTCTTTCAGTCCTACAA-3'
H9-151-168 5'-TATATCCCCATATACCCATTTCTTTCATGACATCTCGGGCAAGTCTTTCAGTCCTACAA-3'
Oligonucleotides with a first mismatch at position 153 and a second mismatch in various distance to the first
H153-1T 5'-TATATCCCCATATACCCATCTCTTTCATGACATCGCAGGCAAGTCTTTCAGTCCTACAA-3'
C153-147 5'-TATATCCCCATATACCCATCTCTTTCATGACATCGCAGGCGAGTCTTTCAGTCCTACAA-3'
C153-150 5'-TATATCCCCATATACCCATCTCTTTCATGACATCGCAAGCAAGTCTTTCAGTCCTACAA-3'
C153-156 5'-TATATCCCCATATACCCATCTCTTTCATGACGTCGCAGGCAAGTCTTTCAGTCCTACAA-3'
C153-159 5'-TATATCCCCATATACCCATCTCTTTCATAACATCGCAGGCAAGTCTTTCAGTCCTACAA-3'
Oligonucleotides with a first mismatch at position 151 and a second mismatch in various distance to the first
O45-151-147 5'-C*C*C*A*TCTCTTTCATGACATCTCGGGCGAGTCTTTCAGTCCT*A*C*A*A-3'
O45-151-150 5'-C*C*C*A*TCTCTTTCATGACATCTCGAGCAAGTCTTTCAGTCCT*A*C*A*A-3'
O42-151-156 5'-T*C*C*C*ATCTCTTTCATGACGTCTCGGGCAAGTCTTTCAG*T*C*C*T-3'
O45-151-159 5'-C*C*C*A*TCTCTTTCATAACATCTCGGGCAAGTCTTTCAGTCCT*A*C*A*A-3'
Oligonucleotides in different length with a first mismatch at position 151 and a second mismatch at position 159
O-25-151C-159T 5'-T*T*T*C*ATAACATCTCGGGCAAG*T*C*T*T-3'
O-30-151C-159T 5'-C*T*C*T*T TCATAACATCTCGGGCAAGTC*T*T*T*C-3'
O-45-151C-159T 5'-C*C*C*A*TCTCTTTCATAACATCTCGGGCAAGTCTTTCAGTCCT*A*C*A*A-3'
O-48-151C-159T 5'-C*C*T*C*CCATCTCTTTCATAACATCTCGGGCAAGTCTTTCAGTCCT*A*C*A*A-3'
The 5' TA-clamps are indicated in italics and the phosphorothioates are indicated by asterisks. The positions of the first and second mismatch are 
indicated in bold and underlined.BMC Molecular Biology 2008, 9:14 http://www.biomedcentral.com/1471-2199/9/14
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Table 3: Percentage of clones with both exchanges obtained with different oligonucleotides
Positions 153 and 147 (in different distances to the 3'-end)
Oligonucleotide Distance of position 147 to the 3'-end 
(number of nucleotides)
number of clones per 
106transfected cells
% of clones with both exchanges
C47-153-147 6 22 16
C53-153-147 12 13,3 54
C59-153-147 18 9,7 63
C65-153-147 24 8,7 47
C71-153-147 30 6,3 62
Positions 151 + x (TA-clamps)
Oligonucleotide Distance (nucleotides) to the first 
position
number of clones per 
106transfected cells
% of clones with both exchanges
H1-151 - 4.86 -
H7-151-141 -10 4.00 33
H5-151-144 -7 1.67 50
H3-151-147 -4 1.83 91
H2-151-150 -1 1.33 100
H4-151-156 5 2.67 63
H6-151-159 8 1.83 27
H8-151-165 14 4.00 8
H9-151-168 17 6.00 0
Positions 153 + x (TA-clamps)
Oligonucleotide Distance (nucleotides) to the first 
position
number of clones per 
106transfected cells
% of clones with both exchanges
H153-1T - 18.00 -
C-153-147 -6 4.67 50
C-153-150 -3 1.00 100
C-153-156 3 2.67 89
C-153-159 6 5.00 35
Positions 151 + x (PTO modifications)
Oligonucleotide Distance (nucleotides) to the first 
position
number of clones per 
106transfected cells
% of clones with both exchanges
O45-151-147 -4 3.50 64
O45-151-150 -1 0.33 100
O42-151-156 5 6.50 41
O45-151-159 8 1.33 8
Positions 151 + 159, different lengths (PTO modifications)
Oligonucleotide Length of the oligonucleotides 
(nucleotides)
number of clones per 
106transfected cells
% of clones with both exchanges
O25-151-159 25 2.83 12
O30-151-159 30 3.83 13
O45-151-159 45 1.33 13
O48-151-159 48 2.00 17
The number of HAT resistant clones per 106 transfected cells and the percentage of clones showing the simultaneous exchange of both mismatches 
is given depending on the distance of the second mismatch nucleotide to the 3'-end of the oligonucleotide, the distance of the second mismatch to 
the first position or length of the oligonucleotides.BMC Molecular Biology 2008, 9:14 http://www.biomedcentral.com/1471-2199/9/14
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the two mismatches, the lower the rate of clones showing
both nucleotide exchanges is (Table 3). This suggests that
the variation in the rate of simultaneously exchanged
nucleotides is not due to the specific sequence environ-
ment.
Influence of PTO modifications of the oligonucleotides on 
the exchange rates
The question arises as to whether the type of 3'- and 5'-end
modification of the oligonucleotides has an influence on
the variation in the number of clones with two nucleotide
exchanges. We therefore additionally tested oligonucle-
otides with PTO modifications at the 3'- and 5'-end which
we expected to exhibit a better protection against degrada-
tion through exonucleases. These oligonucleotides gener-
ate a first exchange at position 151 and a second at the
positions 147, 150, 156 or 159 (Table 2). As in the exper-
iments with oligonucleotides modified by 5'-TA clamps,
the longer the distance between the two mismatches of
the PTO modified oligonucleotides, the lower the rate of
two simultaneously exchanged nucleotides was (Table 3).
This suggests that this modification of the oligonucle-
otides has no obvious influence on the exchange rate of
the two nucleotides.
The length of the oligonucleotide does not influence the 
exchange rates
In order to test whether the length of the oligonucleotides
influences the rate of simultaneous exchange of two
nucleotides, cells were transfected with oligonucleotides
with lengths of twenty-five, thirty, forty and forty-eight
nucleotides, respectively, all carrying mismatches to the
target sequence at positions 151 and 159 (Fig. 1C). These
oligonucleotides were modified by four PTO at each end
(Table 2). The HAT resistant clones we obtained after
transfection with these oligonucleotides showed no sig-
nificant variation in the rates of simultaneous exchange of
both nucleotides (Table 3). The length of the oligonucle-
otides in the investigated range of twenty-five to forty-
eight nucleotides therefore has no effect on the exchange
rate of two nucleotides.
Taking all our experimental data together we found that
the probability of simultaneous exchange of two nucle-
otides decreases if the distance between them increases
(Fig. 5). We observed a cluster of simultaneously
exchanged nucleotides in a hprt region of about fourteen
nucleotides upstream and downstream of the first
exchange position. No more exchanges of the second
nucleotide could be observed at a distance of more than
fourteen nucleotides. This finding matches with addi-
tional experiments where we have not been able to find
any exchanges of the second mismatch at a distance of
eighteen nucleotides and more (data not shown).
Exchange rate of the second nucleotide Figure 4
Exchange rate of the second nucleotide. Percentage of 
clones with both exchanges after transfection with TA-clamp 
modified oligonucleotides carrying their first exchange nucle-
otide at hprt position 151. The X-axis indicates the distance 
of the second mismatch from the first exchange position in 
upstream and downstream direction.
Correction rate of the first mismatch position Figure 3
Correction rate of the first mismatch position. Cor-
rection rate of the first mismatch position after transfection 
with TA-clamp modified oligonucleotides carrying one mis-
match (striped column) or two mismatches (black columns). 
The first exchange nucleotide was at hprt position 151 and 
the second mismatch at various distances. The X-axis indi-
cates the distance of the second mismatch from the first 
exchange position in upstream and downstream direction. 
The Y-axis shows the mean number of clones obtained per 
106 transfected cells. Mean and standard deviations were cal-
culated based on the total number of clones after 3 – 6 trans-
fection experiments per oligonucleotide (Additional file 1).BMC Molecular Biology 2008, 9:14 http://www.biomedcentral.com/1471-2199/9/14
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Discussion and Conclusion
Our experiments on TNE with oligonucleotides carrying
two mismatches to the target sequence showed that the
longer the distance between the two mismatches, the
lower the observed rate of coincident exchanges is. This
correlation was found to be independent of the length of
the oligonucleotides and two tested terminal modifica-
tions protecting against nucleases. The exchange of the
first nucleotide at position 153 instead of position 151 led
to an increase of the correction efficiency of the first mis-
match but had no influence on the rate of the simultane-
ous exchange of the second nucleotide. We assume that
the exchange of both nucleotides takes place during one
repair step as the very low correction efficiency makes it
quite unlikely that two nucleotides are exchanged inde-
pendently in one cell. Our data correspond to experi-
ments with oligonucleotides carrying two mismatches
using an episomal target in yeast which also indicated that
the closer the two sites are, the more likely it is that both
will be converted [28]. Other groups found that shifting
the mismatch forming nucleotide away from the centre of
the targeting vector leads to a decrease in conversion rates
[28,29]. Since the oligonucleotides used by these groups
had a length of twenty-five nucleotides the reduced cor-
rection efficiency may be a consequence of the smaller dis-
tance of the mismatch nucleotide to the end of the
oligonucleotide. In our experiments defining the minimal
distance of the second mismatch nucleotide from the 3'-
end of the oligonucleotides we have not been able to
observe a higher exchange rate of mismatches lying closer
to the centre of the oligonucleotide. But after transfection
with oligonucleotides carrying their second mismatch in a
distance of only six nucleotides from the 3'-end we found
an increase in the correction rate of the first mismatch and
a decrease in the correction rate of the second mismatch.
We suppose that the reason for this effect is the removal of
the second mismatch through a nuclease activity which
leads to a higher affinity of the remaining oligonucleotide
to the target strand. We have also observed a slight differ-
ence in the rate of second exchanges depending on their
position in 3'- or 5'-direction relative to the first position.
The percentage of exchanged second mismatches was
higher when the mismatch was located in 3'-direction
from the first mismatch position compared to mis-
matches located in the same distance in 5'-direction. A
corresponding observation has been made by other
groups before [29] and they suggested that homology in
5' flanking region is more important for targeted gene
alteration than that in 3' flanking region. Since the rates
do not differ strongly our observation might be normal
variation so we found it not significant enough to draw a
conclusion.
One repair mechanism working within a limited sequence
region and discussed for the second step of TGA is nucle-
otide excision repair (NER). The structure-specific endo-
nucleases XPG and ERCC1/XPF are involved in this repair
mechanism [30,31] and the participation of these endo-
nucleases in oligonucleotide-directed gene alteration has
recently been shown [16]. The limited NER repair region
of 22 – 32 nucleotides may be related to our observation
of a restricted exchange region. Another repair mechanism
working within a limited sequence region is base excision
repair (BER) which can be divided into short-patch and
long-patch repair. Long-patch repair leads to the exchange
of a 2 – 15 nucleotide long DNA fragment [32,33] which
would be in line with our findings.
Another repair mechanism that seems to influence TGA is
the MMR [34,35]. Especially the MMR protein MSH2 has
been shown to suppress the frequency of TGA [19,36].
The influence of specific repair mechanisms on the simul-
taneous exchange of two nucleotides should be further
examined, especially the function of MSH2.
Beside the usage of the oligonucleotide as a matrix for a
specific repair mechanism, another possible pathway of
TNE is the physical incorporation of the oligonucleotide
Fitted exchange rate of the second nucleotide after transfec- tion with differently modified oligonucleotides Figure 5
Fitted exchange rate of the second nucleotide after 
transfection with differently modified oligonucle-
otides. Percentage of clones with both exchanges after dif-
ferent transfection experiments with oligonucleotides 
carrying two mismatches to hprt. The X-axis indicates the 
distance of the second mismatch (independent of its position 
in upstream or downstream direction) from the first 
exchange position.   first mismatch at position 151, modified 
by TA-clamps. * : first mismatch at position 153, modified 
by TA-clamps.   : first mismatch at position 151, modified by 
PTO. The black line shows the linear fit of the data points 
from the experiments with the three different kinds of oligo-
nucleotides.BMC Molecular Biology 2008, 9:14 http://www.biomedcentral.com/1471-2199/9/14
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into the target strand [18]. There are evidences that the
incorporation of the oligonucleotide occurs in a replica-
tion-dependent way [12,37-41]. The oligonucleotide
might serve as an Okazaki fragment and become incorpo-
rated into the lagging strand. Okazaki fragments have a
length of up to 125 nucleotides [42,43]. Alternatively, the
oligonucleotide might serve as a primer for the synthesis
of an Okazaki fragment by DNA-Polymerase δ instead of
a RNA primer. The length of these primers synthesized by
primase is 7–10 ribonucleotides [44].
However, the cluster we observed for the simultaneous
exchange of two mismatches of about fourteen nucle-
otides is shorter than the oligonucleotides used. One pos-
sible explanation to fit our findings into the theory of an
annealing oligonucleotide which then gets incorporated
into the target DNA might be the activity of nucleases.
Radecke and colleagues [18] suggest that nucleases might
play a role in TGA by rendering transfected oligonucle-
otides competent for gene correction. It may therefore be
hypothesized that the primary oligonucleotide is proc-
essed by nucleases to a biologically active shortened mol-
ecule. During this process the second mismatch might be
removed, depending on its distance to the first. The fur-
ther apart the two mismatches are, the higher the proba-
bility would be that they are separated through a
degradation process. We suggest, that the oligonucleotide
modifications used for protection against nuclease degra-
dation only work for a very short time but finally also
underlie degradation processes.
A observation that supports the hypothesis of a shortened
biologically active oligonucleotide is that we found an
increased number of clones after transfection with oligo-
nucleotides which carried their second mismatch at a dis-
tance of ten and more nucleotides from the first exchange
position compared to oligonucleotides with a second mis-
match at a distance of less than ten nucleotides from the
first exchange position. The loss of the second mismatch
after nuclease cleavage might have led to a higher affinity
of the shortened oligonucleotide to the target sequence
and therefore to a number of clones in the range of oligo-
nucleotides carrying only one mismatch. To better under-
stand the mechanisms underlying TGA further
experiments to identify the actual length of the biologi-
cally active form of the oligonucleotide should be per-
formed. This could be done by recovering labelled
oligonucleotides from corrected cells. Since our experi-
ments showed that transfection of cells with gene-specific,
single-stranded oligonucleotides can induce the exchange
of nucleotides at various genomic positions the occurance
of unexpected exchanges should also be carefully exam-
ined. This is especially important for the potential appli-
cation of TGA in gene therapy.
In summary, we observed that the simultaneous exchange
of a second nucleotide clusters within a region of about
fourteen nucleotides around the first target nucleotide.
We suggest that the biologically active form of the oligo-
nucleotide which is relevant for TNE is only a part of the
entire oligonucleotide sequence. The observed limited
exchange region might be either the effect of a specific
repair mechanism which uses the oligonucleotide as a
matrix or due to intercellular emerging degraded oligonu-
cleotides which might also serve as a matrix for the dis-
cussed repair mechanisms or be physically incorporated
into the target strand.
Methods
Cell line and cell culture
A point mutation at position 151 (C → T) of the hprt gene
which leads to a stop codon was generated through incu-
bation of V79 cells with ethylmethanesulfonate [2] (Table
1). The V79-151 cells were cultured in DMEM containing
ten per cent FBS and maintained at 37°C and five per cent
CO2. Their doubling time is of about sixteen hours and
their G1 phase is therefore very short (six hours). Prior to
the transfection experiments, the V79-151 cells were rese-
lected against intact hprt-containing cells by incubation
with 6-thioguanine (1 μg/ml) for seven days [27].
Single-stranded oligonucleotides for the correction of the 
hprt mutation and the generation of an additional 
nucleotide exchange
The single-stranded oligonucleotides (Thermo Electron
Corporation, Ulm, Germany)were directed to the non-
transcribed strand of hprt. They contained one mismatch
to the hprt sequence of V79-151 cells on cDNA position
151 or 153 (Table 2). For protection against degradation
the oligonucleotides were modified either with a TA-
clamp at the 5'-end or four phosphorothioates (PTO) on
each side. The TA-clamps were constructed on the basis of
experiments with the first generation of oligonucleotides
for the targeted gene alteration with DNA/RNA-hybrids in
which oligonucleotides with symmetric GC-clamps were
used [45]. It consists of two complementary sequences of
five alternating thymines and adenines which are linked
by four cytosines and form a double-stranded loop. The
length of the oligonucleotides varied between twenty-five
and seventy-one nucleotides and most of the oligonucle-
otides carried a second mismatch to the hprt sequence to
generate an additional nucleotide exchange at the posi-
tions 141, 144, 147, 150, 156, 159, 165 or 168 (Table 2).
To examine the spontaneous nucleotide exchange rate
from T to C at hprt position 151 of the V79-151 cells we
carried out experiments in which we either transfected
them with oligonucleotides not carrying a mismatch to
the target sequence or did not treat them with oligonucle-BMC Molecular Biology 2008, 9:14 http://www.biomedcentral.com/1471-2199/9/14
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otides. The spontaneous nucleotide exchange rate we
observed at position 151 was about 0,025 of 106 cells.
Transfection of hprt (-) V79 cells and selection of hprt (+) 
cells
Hprt  (-) V79-151 cells were transfected by a magnet-
assisted transfection-system (MATra-A, IBA GmbH, Gött-
ingen, Germany). One day prior to transfection, 104 cells
per well were seeded on a 96-well plate. The oligonucle-
otides (10 μl, 100 pmol/μl) were incubated with 10 μl
MATra-A Reagent and 500 μl serum-free medium at 25°C
for fifteen minutes. The solution was then added to 19.6
ml DMEM and 200 μl of the mixture was pipetted into
each well. The cells were transfected for sixty minutes on
a magnetic plate. Afterwards they were cultured for an
additional twenty-four hours in normal culture medium,
and selected for three weeks by incubation with HAT
medium (InVitrogen Life Technologies, Karlsruhe, Ger-
many). About four hours after the addition of HAT hprt
deficient V79-151 cells started to die. In some experiments
the cells were transfected with polyethylenimine (PEI,
ExGen500, Euromedex, Mundolsheim Cedex, France) as
described before [27]. The surviving clones were counted
and subcloned in HAT medium.
Investigation of hprt sequence alterations in the HAT 
selected clones
If the number of clones received per transfection experi-
ment was very high, only about fifteen clones per oligonu-
cleotide were sequenced (Additional file 1). The DNA of
the HAT selected cell clones was isolated using the QIAmp
DNA Blood Mini Kit (Qiagen, Hilden, Germany), quanti-
fied by measuring the optical density at 260 nm, and its
quality investigated on a 1.5 per cent agarose gel stained
with ethidium bromide. The following primer pairs were
used for the PCR amplification: 12Hin (5'-TGT GTA AGT
ATA ATC TCA GC-3') binding in intron two and 12Rueck
(5'-ACA CAG TAG CTC TTC AGT CT-3') binding in exon
three; HPRT-Hin5 (5'-TAT TCC GTG ATT TTA TTT TTG
TAG-3') binding in intron two and HPRT-Rueck5 (5'-ATG
GAT CTA TCA CTA TTT CTA TT-3') binding in exon three.
The obtained PCR products have a length of 462 bp and
160 bp respectively. The amplification conditions in a
Perkin Elmer GeneAmp 9700 were five minutes at 94°C,
thirty-five cycles at 94°C for thirty seconds, 48°C for
thirty seconds and 72°C for thirty seconds and a final
elongation for seven minutes at 72°C. The PCR products
were purified with the Montage PCR Kit (Millipore, Bed-
ford, MA, USA) and sequenced on an ABI 3100 auto-
mated sequencer (PE Applied Biosystems, Foster City, CA,
USA).
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